Frankfurt - Delayed Quote EUR
Novo Nordisk A/S (NOV.F)
57.88
-0.96
(-1.63%)
As of 9:12:30 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
131,245,000
120,968,000
108,908,000
78,887,000
55,000,000
Investing Cash Flow
-139,524,000
-128,895,000
-43,892,000
-24,918,000
-31,605,000
Financing Cash Flow
40,568,000
8,735,000
-63,158,000
-51,797,000
-25,493,000
End Cash Position
38,613,000
15,655,000
14,392,000
12,653,000
10,719,000
Capital Expenditure
-56,886,000
-51,309,000
-38,896,000
-14,753,000
-7,385,000
Issuance of Debt
106,754,000
79,391,000
0
11,215,000
22,160,000
Repayment of Debt
-18,050,000
-6,335,000
-1,467,000
-13,623,000
-6,689,000
Repurchase of Capital Stock
-18,733,000
-20,181,000
-29,924,000
-24,086,000
-19,447,000
Free Cash Flow
74,359,000
69,659,000
70,012,000
64,134,000
47,615,000
12/31/2021 - 11/19/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LLY.F Eli Lilly and Company
648.70
-3.18%
0R34.IL Johnson & Johnson
146.70
-1.54%
NOTA.F Novartis AG
93.60
-3.51%
AMG.F Amgen Inc.
235.65
-4.46%
7XP.F Organon & Co.
7.21
-3.66%
RHO5.DU Roche Holding AG
268.40
-2.79%
BRM.DE Bristol-Myers Squibb Company
40.74
-3.13%
ZEGA.F AstraZeneca PLC
60.50
-0.82%
LLYC.VI Eli Lilly and Company
647.90
-3.53%
JNJd.XC